comScore Q2 results likely to beat expectations, says Cantor Cantor thinks that comScore's new products are gaining traction, and the firm expects the company's operating leverage to continue throughout the rest of 2014. It predicts that comScore's partnerships and deals should boost its growth in 2015 and beyond, and keeps a $36 price target and Buy rating on the shares.
On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: AMAG Pharmaceuticals (AMAG) initiated with an Outperform at Northland... Angie's List (ANGI) initiated with a Neutral at Roth Capital... Bio Blast Pharma (ORPN) initiated with a Buy at Rodman & Renshaw... British American Tobacco (BTI) initiated with a Buy at UBS... Imperial Tobacco (ITYBY) initiated with a Buy at UBS... Instructure (INST) initiated with an Outperform at Barrington... Nektar (NKTR) initiated with a Buy at Janney Capital... Par Pacific (PARR) initiated with an Outperform at Imperial Capital... Pure Storage (PSTG) initiated with a Buy at Maxim... comScore (SCOR) initiated with a Hold at Evercore ISI.